Bio-Behavioral Predictors of the Efficacy of Nicotine Replacement Therapy (NRT)

PHASE4CompletedINTERVENTIONAL
Enrollment

674

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions
Smoking
Interventions
DRUG

Nicoderm Transdermal Patch

The dosing schedule is as follows: 4 weeks of 21mg per 24 hours, 2 weeks of 14mg per 24 hours, and 2 weeks of 7mg per 24 hours. Treatment lasted 8 weeks.

DRUG

Nicotine Nasal Spray

8 weeks of self-administered nicotine nasal spray at 40 recommended doses per day, tapering by 1/3 for the last 4 weeks. Nasal spray dosing was 0.5 mg spray per nostril (1 mg) for a maximum of 5 doses per hour and 40 doses per day. This dosing schedule is based on the average nicotine intake per cigarette of 1 mg per cigarette. Treatment lasted 8 weeks.

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Pennsylvania

OTHER

NCT00326781 - Bio-Behavioral Predictors of the Efficacy of Nicotine Replacement Therapy (NRT) | Biotech Hunter | Biotech Hunter